67 related articles for article (PubMed ID: 38308276)
1. The Role of
Chen X; Poetsch A
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672271
[TBL] [Abstract][Full Text] [Related]
2. DNMT3L inhibits hepatocellular carcinoma progression through DNA methylation of CDO1: insights from big data to basic research.
Yan X; Qi Y; Yao X; Zhou N; Ye X; Chen X
J Transl Med; 2024 Feb; 22(1):128. PubMed ID: 38308276
[TBL] [Abstract][Full Text] [Related]
3. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
[TBL] [Abstract][Full Text] [Related]
4. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
5. miR-4270 suppresses hepatocellular carcinoma progression by inhibiting DNMT3A-mediated methylation of HGFAC promoter.
Zou Q; Cao S
PeerJ; 2023; 11():e16566. PubMed ID: 38077422
[TBL] [Abstract][Full Text] [Related]
6. DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells.
Kim H; Park J; Jung Y; Song SH; Han SW; Oh DY; Im SA; Bang YJ; Kim TY
Int J Oncol; 2010 Jun; 36(6):1563-72. PubMed ID: 20428781
[TBL] [Abstract][Full Text] [Related]
7. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.
Wu H; Zhang W; Wu Z; Liu Y; Shi Y; Gong J; Shen W; Liu C
Cell Death Dis; 2019 Jan; 10(2):48. PubMed ID: 30718452
[TBL] [Abstract][Full Text] [Related]
8. Mechanism studies of the activation of DNA methyltransferase DNMT1 triggered by histone H3 ubiquitination, revealed by multi-scale molecular dynamics simulations.
Sun J; Liu F; Yuan L; Pang NN; Zhu B; Yang N
Sci China Life Sci; 2023 Feb; 66(2):313-323. PubMed ID: 36271982
[TBL] [Abstract][Full Text] [Related]
9. The lipid transporter HDLBP promotes hepatocellular carcinoma metastasis through BRAF-dependent epithelial-mesenchymal transition.
Yuan J; Lv T; Yang J; Wu Z; Yan L; Yang J; Shi Y; Jiang L
Cancer Lett; 2022 Nov; 549():215921. PubMed ID: 36122630
[TBL] [Abstract][Full Text] [Related]
10. Big data in basic and translational cancer research.
Jiang P; Sinha S; Aldape K; Hannenhalli S; Sahinalp C; Ruppin E
Nat Rev Cancer; 2022 Nov; 22(11):625-639. PubMed ID: 36064595
[TBL] [Abstract][Full Text] [Related]
11. TET enzymes regulate skeletal development through increasing chromatin accessibility of RUNX2 target genes.
Wang L; You X; Ruan D; Shao R; Dai HQ; Shen W; Xu GL; Liu W; Zou W
Nat Commun; 2022 Aug; 13(1):4709. PubMed ID: 35953487
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation: Precise modulation of chromatin structure and dynamics.
Li S; Peng Y; Panchenko AR
Curr Opin Struct Biol; 2022 Aug; 75():102430. PubMed ID: 35914496
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation-mediated expression of zinc finger protein 615 affects embryonic development in
Xu GF; Gong CC; Tian YL; Fu TY; Lin YG; Lyu H; Peng YL; Tong CM; Feng QL; Song QS; Zheng SC
Zool Res; 2022 Jul; 43(4):552-565. PubMed ID: 35616260
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
